247 related articles for article (PubMed ID: 25875520)
1. [Hereditary diffuse gastric cancer].
Melo Pezo X; Medrano Samamé H; Torres Rosas E
Rev Gastroenterol Peru; 2015 Jan; 35(1):73-8. PubMed ID: 25875520
[TBL] [Abstract][Full Text] [Related]
2. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
3. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].
Svrcek M
Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246
[No Abstract] [Full Text] [Related]
4. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
[TBL] [Abstract][Full Text] [Related]
5. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
Cisco RM; Norton JA
Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary diffuse gastric cancer].
Sezeur A; Schielke A; Larue L; Fléjou JF
Gastroenterol Clin Biol; 2006 Oct; 30(10):1205-13. PubMed ID: 17075480
[TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
8. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
[TBL] [Abstract][Full Text] [Related]
10. Hereditary gastric cancer.
Carneiro F
Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
[TBL] [Abstract][Full Text] [Related]
12. Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer.
Chung DC; Yoon SS; Lauwers GY; Patel D
N Engl J Med; 2007 Jul; 357(3):283-91. PubMed ID: 17634464
[No Abstract] [Full Text] [Related]
13. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.
Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC
Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763
[TBL] [Abstract][Full Text] [Related]
14. Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome.
Friedman M; Adar T; Patel D; Lauwers GY; Yoon SS; Mullen JT; Chung DC
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):189-191. PubMed ID: 31678201
[TBL] [Abstract][Full Text] [Related]
15. Synchronous appendiceal and intramucosal gastric signet ring cell carcinomas in an individual with CDH1-associated hereditary diffuse gastric carcinoma: a case report of a novel association and review of the literature.
Hamilton LE; Jones K; Church N; Medlicott S
BMC Gastroenterol; 2013 Jul; 13():114. PubMed ID: 23849133
[TBL] [Abstract][Full Text] [Related]
16. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?
Shaw D; Blair V; Framp A; Harawira P; McLeod M; Guilford P; Parry S; Charlton A; Martin I
Gut; 2005 Apr; 54(4):461-8. PubMed ID: 15753528
[TBL] [Abstract][Full Text] [Related]
17. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
Kumar S; Long JM; Ginsberg GG; Katona BW
World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
[TBL] [Abstract][Full Text] [Related]
18. No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer.
Tanis PJ; Ten Kate FJ; van Lanschot JJ
J Surg Oncol; 2008 Mar; 97(3):294-6. PubMed ID: 18161866
[TBL] [Abstract][Full Text] [Related]
19. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
Zhang Q; Yang Z; Karamchandani DM
Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
[TBL] [Abstract][Full Text] [Related]
20. Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy.
Inaba Y; Goda K; Kondo M; Abe K; Kanamori A; Suzuki T; Tominaga K; Nakagawa M; Morita S; Kojima K; Ishida K; Irisawa A
Intern Med; 2024 Jan; 63(2):235-239. PubMed ID: 37225495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
